BRYAN HAINLINE, M.D.
Ophthalmology Physician · RICHMOND, IN
Individual Active NPI 1073711966
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,376 | 42,168 | $10,723,601 | $4,942,873 | $3,854,526 |
| 2023 | 1,471 | 34,277 | $9,793,986 | $4,738,056 | $3,705,939 |
| 2022 | 1,601 | 31,710 | $10,029,019 | $4,755,027 | $3,709,051 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 10,320 | $35 | $27 |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 7,425 | $6 | $5 |
| 92134 | Imaging of retina | 5,555 | $37 | $28 |
| 67028 | Injection of drug into eye | 4,290 | $103 | $80 |
| J0178 | Injection, aflibercept, 1 mg | 2,862 | $819 | $647 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 2,120 | $108 | $86 |
| J3590 | Unclassified biologics | 1,747 | $53 | $40 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 1,713 | $119 | $84 |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,642 | $157 | $122 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,055 | $225 | $177 |
| 66984 | Removal of cataract with insertion of prosthetic lens | 338 | $384 | $298 |
| 92273 | Measurement of retinal and optic nerve function | 324 | $115 | $80 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 01059329A | IN |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Indiana
- NPI 1174850846
- NPI 1831180678
- NPI 1144203274
- NPI 1700869179
- NPI 1831651488
- NPI 1083940936
- NPI 1215082813
- NPI 1962635052
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.